GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like 3 Intriguing Small-Cap Biotechs to Put on Your Watchlist April 19, 2017 Eleven Bio Reports Fourth Quarter And Full Year 2016 Financial Results March 23, 2017 NIH Hooks Up With 11 Top Biopharmas for $215 Million Cancer Moonshot Deal October 12, 2017
